Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report.

Authors :: Goldman, S
Smith, L
Anderson, J R
Perkins, S
Harrison, L
Geyer, M B
Gross, T G
Weinstein, H
Bergeron, S
Shiramizu, B
Sanger, W
Barth, M
Zhi, J
Cairo, M S
Source :: Leukemia (08876924); May2013, Vol. 27 Issue 5, p1174-1177, 4p, 2 Graphs
Publication Year :: 2013
Abstract: A letter to the editor is presented regarding the effectiveness of rituximab with multiagent chemotherapy regimens in the treatment of advanced mature B-cell non-Hodgkin lymphoma (B-NHL) in children and adolescents.

Full Text Access

Tools